Patents by Inventor William F. Hoffman

William F. Hoffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8264777
    Abstract: A portable electronic device (510) having a self illuminating display (200, 202, 204, 206, 300, 512) that reduces both the thickness of known displays and processing steps in the fabrication thereof is provided. The portable electronic device (510) includes an electrowetting display (200, 202, 204, 206, 300, 512) having a plurality of transparent layers defining a cavity (219). A combination of a first fluid (218, 236) and a second fluid (210, 234, 244, 254) are positioned in the cavity. First circuitry (224) is configured to be coupled to a first voltage source (222) for selectively repositioning the second fluid (210, 234, 244, 254) in relation to the first fluid (218, 236). A plurality of quantum dots (208, 360) is positioned within the second fluid (210, 234, 244, 254), and a light source (209, 309) is disposed contiguous to the plurality of layers.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: September 11, 2012
    Assignee: QD Vision, Inc.
    Inventors: Andrew F. Skipor, Marc K. Chason, William F. Hoffman, Krishna Kalyanasundaram, George T. Valliath
  • Patent number: 8184359
    Abstract: A laser projector display module for a handheld device may include an electronics module, a miniaturized light source module electrically connected with the electronics module, a scanner module electrically connected with the electronics module, and an optical assembly configured to direct light from the light source onto the scanner module. The scanner module and the light source module may abut the electronics module.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: May 22, 2012
    Assignee: Motorola Mobility, Inc.
    Inventors: William F. Hoffman, Tomasz L. Klosowiak, Lawrence E. Lach, Junhua Liu, Ion V. Nicolaescu, Min-Xian M. Zhang
  • Publication number: 20090002806
    Abstract: A portable electronic device (510) having a self illuminating display (200, 202, 204, 206, 300, 512) that reduces both the thickness of known displays and processing steps in the fabrication thereof is provided. The portable electronic device (510) includes an electrowetting display (200, 202, 204, 206, 300, 512) having a plurality of transparent layers defining a cavity (219). A combination of a first fluid (218, 236) and a second fluid (210, 234, 244, 254) are positioned in the cavity. First circuitry (224) is configured to be coupled to a first voltage source (222) for selectively repositioning the second fluid (210, 234, 244, 254) in relation to the first fluid (218, 236). A plurality of quantum dots (208, 360) is positioned within the second fluid (210, 234, 244, 254), and a light source (209, 309) is disposed contiguous to the plurality of layers.
    Type: Application
    Filed: June 26, 2007
    Publication date: January 1, 2009
    Applicant: MOTOROLA, INC.
    Inventors: Andrew F. Skipor, Marc K. Chason, William F. Hoffman, Krishna Kalyanasundaram, George T. Valliath
  • Publication number: 20080274107
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Application
    Filed: April 21, 2008
    Publication date: November 6, 2008
    Inventors: Mark E. Fraley, Kenneth L. Arrington, Mark T. Bilodeau, George D. Hartman, William F. Hoffman, Yuntae Kim, Randall W. Hungate
  • Publication number: 20080210929
    Abstract: An organic thin film transistor is formed using an organic semiconducting polymer that contains electrically conductive micro scale or nanoscale metallic plates, particulates, or rods dispersed in the polymer at a concentration less than the percolation threshold to form a semiconducting matrix. The electrically conductive particulates are dispersed to provide a multidimensional micro scale network so that the materials do not provide electrical conductivity between themselves but only between an individual particulate and the organic semiconductor. The transconductance value of the semiconducting matrix is at least one order of magnitude greater than the transconductance value of the neat organic semiconductor, providing a switching speed from an ‘off’ state to an ‘on’ state at least one order of magnitude greater than a switching speed of the neat organic semiconductor.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 4, 2008
    Applicant: Motorola, Inc.
    Inventors: William F. Hoffman, Andrew F. Skipor
  • Publication number: 20080172197
    Abstract: A display (1100) comprises a passive screen (106, 502, 700, 1114) printed with a pattern (404) of different color quantum dots (602, 604, 606) that is excited by scanning a laser (130, 1108) over the screen (106, 502, 700, 1114). The display (1100) can be incorporated into a handheld device (100, 1200) to improve the use-ability of the device (100, 1200).
    Type: Application
    Filed: January 11, 2007
    Publication date: July 17, 2008
    Applicant: MOTOROLA, INC.
    Inventors: Andrew F. Skipor, Marc K. Chason, William F. Hoffman, Krishna D. Jonnalagadda, Mark A. Tarlton, George T. Valliath, Jerzy Wielgus
  • Publication number: 20080158653
    Abstract: A laser projector display module for a handheld device may include an electronics module, a miniaturized light source module electrically connected with the electronics module, a scanner module electrically connected with the electronics module, and an optical assembly configured to direct light from the light source onto the scanner module. The scanner module and the light source module may abut the electronics module.
    Type: Application
    Filed: December 27, 2006
    Publication date: July 3, 2008
    Applicant: Motorola, Inc.
    Inventors: William F. Hoffman, Tomasz L. Klosowiak, Lawrence E. Lach, Junhua Liu, Ion V. Nicolaescu, Min-Xian M. Zhang
  • Patent number: 7378411
    Abstract: The present invention relates to thienopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: May 27, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, George D. Hartman, William F. Hoffman
  • Patent number: 7348440
    Abstract: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: March 25, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Kenneth L. Arrington, Paul J. Coleman, Christopher D. Cox, Mark E. Fraley, Robert M. Garbaccio, George D. Hartman, William F. Hoffman, Edward S. Tasber
  • Patent number: 7329762
    Abstract: The present invention relates to phosphate ester prodrugs of dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: June 8, 2004
    Date of Patent: February 12, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, Robert M. Garbaccio, George D. Hartman, William F. Hoffman
  • Patent number: 7262187
    Abstract: The present invention relates to azolopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: August 28, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, George D. Hartman, William F. Hoffman
  • Patent number: 7262186
    Abstract: The present invention relates to azolopyriniidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: August 28, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, George D. Hartman, William F. Hoffman
  • Patent number: 7251569
    Abstract: Methods, systems, and computer program products for analyzing a product are disclosed. The product includes parts supplied by suppliers. Each part includes materials, each material includes substances, and each substance has a respective substance amount. A database includes relationship information for the product, parts, materials, substances and substance amounts. The product is analyzed by, first, receiving instructions to select at least one of the product, the parts, or the materials for analysis. Next, responsive to the received instructions, relationship information is retrieved from the database for the selected product, parts, and materials. Finally, the retrieved relationship information is processed to determine at least one of (1) a materials breakdown or (2) a compliance status for the selected product, parts, or materials.
    Type: Grant
    Filed: January 26, 2005
    Date of Patent: July 31, 2007
    Assignee: Synapsis Enterprise LLC
    Inventors: P. German Avila, William F. Hoffman, III, Kurk W. Kan, Andrew M. Wertkin
  • Patent number: 7186723
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Grant
    Filed: August 26, 2002
    Date of Patent: March 6, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Jennifer P. Peckham, William F. Hoffman, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Yuntae Kim, Barbara Hanney, Keith L. Spencer
  • Patent number: 7109204
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: September 19, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, Kenneth L. Arrington, William F. Hoffman, George D. Hartman, Jennifer P. Peckham
  • Patent number: 7060705
    Abstract: The present invention relates to quinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: June 13, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, William F. Hoffman
  • Publication number: 20040249042
    Abstract: A coating for assisting in the removal of components from devices comprising a polymer and a microwave absorbing substance dispersed in the polymer, so that when the coating is applied on a surface of a device and overlaid with a component and exposed to microwaves, the microwave absorbing substance absorbs the microwaves and allows for the component to be separated from the device.
    Type: Application
    Filed: June 9, 2003
    Publication date: December 9, 2004
    Applicant: MOTOROLA, INC.
    Inventors: Steven M. Scheifers, William F. Hoffman
  • Publication number: 20040235875
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Application
    Filed: January 29, 2004
    Publication date: November 25, 2004
    Inventors: Mark E. Fraley, Kenneth L Arrington, William F Hoffman, George D Hartman, Jennifer P Peckham
  • Publication number: 20040235826
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Application
    Filed: February 24, 2004
    Publication date: November 25, 2004
    Inventors: Jennifer P. Peckham, William F. Hoffman, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Yuntae Kim, Barbara Hanney, Keith L. Spencer
  • Patent number: 6794393
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: September 21, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, Kenneth L. Arrington, Mark T. Bilodeau, George D. Hartman, William F. Hoffman, Yuntae Kim, Randall W. Hungate